Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cardio Diagnostics Holdings, Inc. (CDIO)

1.04   -0.05 (-4.59%) 01-27 15:59
Open: 1.15 Pre. Close: 1.09
High: 1.1508 Low: 1.04
Volume: 14,582 Market Cap: 10(M)

Technical analysis

as of: 2023-01-27 4:43:15 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.44     One year: 1.69
Support: Support1: 0.88    Support2: 0.74
Resistance: Resistance1: 1.23    Resistance2: 1.45
Pivot: 1.17
Moving Average: MA(5): 1.11     MA(20): 1.14
MA(100): 4.57     MA(250): 7.78
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 19.5     %D(3): 31.8
RSI: RSI(14): 37.1
52-week: High: 10.25  Low: 0.79
Average Vol(K): 3-Month: 176 (K)  10-Days: 16 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CDIO ] has closed above bottom band by 16.8%. Bollinger Bands are 80% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.15 - 1.16 1.16 - 1.17
Low: 1.02 - 1.03 1.03 - 1.04
Close: 1.03 - 1.04 1.04 - 1.05

Company Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Headline News

Sun, 29 Jan 2023
Bohemian, Cathrine Dufour's 2021 European Reserve Champion ... - | Eurodressage

Thu, 26 Jan 2023
Statement from Agriculture Secretary Vilsack on Departure of Deputy ... -

Tue, 24 Jan 2023
HMRC seeks finance chief to manage £1bn digital and IT spend - Public Technology

Fri, 20 Jan 2023
This UK government CDIO role has a salary of £54k: We’re a little dismayed - The Stack

Tue, 17 Jan 2023
Attorney General Bonta Announces Hiring of California Department ... - California Department of Justice

Fri, 06 Jan 2023
Robust access tools and comprehensive IAM promote growth - Mobihealth News

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 24.3 (%)
% Held by Institutions 57.6 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.